Can IGF-1 LR3 be prescribed?

What is IGF-1 LR3, and why are people interested?

IGF-1 LR3 is a modified version of insulin-like growth factor 1, a signal involved in tissue growth. Its structure changes how it interacts with IGF-binding proteins, which makes it interesting to researchers studying growth signaling. That biology helps explain interest in muscle and recovery, but laboratory findings do not establish what a person will gain from treatment. The foundational research examines those molecular differences.

If your goal is staying strong, training consistently or recovering well, make that goal the starting point. It gives a clinician a clearer way to compare relevant options than choosing a peptide by name alone.

Is IGF-1 LR3 approved for muscle growth or recovery?

No FDA-approved IGF-1 LR3 product establishes benefits for muscle growth, recovery or fat loss. Human clinical evidence for those uses is not established. IGF-1 LR3 is also different from mecasermin, an approved IGF-1 medicine used for specific growth disorders; that medicine's approval cannot be transferred to this analogue. Our IGF-1 LR3 evidence guide separates the biological rationale from demonstrated treatment outcomes.

What do FDA compounding rules mean for access?

A patient-specific prescription and a licensed pharmacy are important parts of care. The ingredient and preparation must also meet the applicable compounding requirements. FDA's 503A framework considers relevant USP or NF standards, components of approved drugs and the agency's bulks list. Absence from a safety-warning list does not itself establish eligibility. Read FDA's explanation of the requirements.

FDA’s 2020 warning letter to a compounder specifically included IGF-1 LR3 among ingredients whose preparations did not qualify for the 503A exemptions in the circumstances described. For a proposed preparation, the dispensing pharmacy should confirm its current basis for supply. Read the letter.

What should you ask before considering IGF-1 LR3?

• Does the evidence match my goal? Ask which findings involve this exact analogue and people with a situation like yours.
• Which options should we compare? Discuss the reasons for a particular approach, including options with stronger human evidence where appropriate.
• What would the safety review involve? Discuss medications, glucose control, medical history and what monitoring would be needed.
• Can the proposed preparation be lawfully supplied? Confirm the dispensing pharmacy and the current basis for compounding it.

Can tested athletes use IGF-1 LR3?

The 2026 WADA Prohibited List prohibits IGF-1 and its analogues at all times. A prescription alone does not override anti-doping rules. Athletes subject to testing should check with their governing body before considering it.

What does AnthologyRX bring to the conversation?

AnthologyRX connects your goals with independent clinician review and a licensed US pharmacy dispensing pathway. We have verified our compounding partners’ quality programs, including identity and potency testing, batch documentation, independent testing and sterile-product controls for injectables. Our pharmacy-quality guide explains those safeguards and how they differ from a research-use purchase.

Where can you compare your options?

Explore our IGF-1 LR3 information and comparison with CJC-1295/ipamorelin, then bring your goals to a licensed clinician.